The effects of chitosan/miR-200c nanoplexes on different stages of cancers in breast cancer cell lines.
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Marmara University, Tıbbiye Street, 34668 Istanbul, Turkey.
Kubra
K
Kaban
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Inonu University, Central Campus, 44280 Malatya, Turkey.
Emine
E
Salva
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Marmara University, Tıbbiye Street, 34668 Istanbul, Turkey. Electronic address: jakbuga@marmara.edu.tr.
Julide
J
Akbuga
D017209:Apoptosis / Q000187:drug effects* / Q000502:physiology; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism; D048271:Chitosan / Q000008:administration & dosage* / Q000737:chemistry / Q000378:metabolism; D004337:Drug Carriers / Q000008:administration & dosage / Q000737:chemistry; D005260:Female; D006801:Humans; D061986:MCF-7 Cells; D035683:MicroRNAs / Q000008:administration & dosage* / Q000737:chemistry / Q000378:metabolism; D009367:Neoplasm Staging / Q000379:methods; D016896:Treatment Outcome
D004337:Drug Carriers; C533896:MIRN200 microRNA, human; D035683:MicroRNAs; D048271:Chitosan
Breast cancer; Chitosan; miR-200c; miRNA delivery system